Viking Therapeutics, Inc. (VKTX)
33.70
-0.23
(-0.68%)
USD |
NASDAQ |
Apr 07, 16:00
35.40
+1.70
(+5.04%)
After-Hours: 05:44
Viking Therapeutics Cash from Investing (TTM) : 341.39M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| Amgen, Inc. | -1.943B |
| Pfizer Inc. | -1.351B |
| Hims & Hers Health, Inc. | -1.025B |
| Structure Therapeutics, Inc. | 90.03M |